Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210 SEER Data: Surveillance, Epidemiology and End Results. 2018; Available from URL: http://seer.cancer.gov/statfacts/html/cervix.html Koh, 2019, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology, J Nat Compr. Cancer Network : JNCCN., 17, 64, 10.6004/jnccn.2019.0001 Salaun, 2019, Good clinical practice recommendations for the use of PET/CT in oncology, Eur J Nucl Med Mol Imaging. Onal, 2013, Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy, Int J Gynecol Cancer., 23, 1104, 10.1097/IGC.0b013e3182989483 Potter, 2018, The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies, Clin Transl Radiat Oncol, 9, 48, 10.1016/j.ctro.2018.01.001 Upasani, 2012, 18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers, Int J Gynecol Cancer., 22, 1031, 10.1097/IGC.0b013e318251046b Arnesen, 2016, Short-course PET based simultaneous integrated boost for locally advanced cervical cancer, Radiat Oncol, 11, 39, 10.1186/s13014-016-0612-z Kerr, 2018, Evaluating the Use of 18F-FDG PET CT for External Beam Radiotherapy Planning in Gynaecological Malignancies, Curr Oncol Rep, 20, 84, 10.1007/s11912-018-0735-5 Lin, 2007, Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET, Int J Radiat Oncol Biol Phys., 67, 91, 10.1016/j.ijrobp.2006.08.017 Ma, 2011, Tumor volume discrepancies between FDG-PET and MRI for cervical cancer, Radiot Oncol: J Eur Soc Ther Radiol Oncol, 98, 139, 10.1016/j.radonc.2010.10.004 Dyk, 2014, Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy, Int J Radiat Oncol Biol Phys, 90, 794, 10.1016/j.ijrobp.2014.07.039 Aerts, 2012, Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation, Lung Cancer, 75, 73, 10.1016/j.lungcan.2011.06.003 van den Bogaard, 2011, Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer, Radiot Oncol: J Eur Soc Ther Radiol Oncol, 99, 137, 10.1016/j.radonc.2011.04.004 Chaput, 2017, Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma, Head Neck, 39, 1155, 10.1002/hed.24738 Calais, 2015, High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer, Eur J Nucl Med Mol Imaging., 42, 858, 10.1007/s00259-015-3004-y Lucia F MO, Abgral R, Visvikis D, Bourbonne V, Dissaux G, Pradier O, Hatt M, Schick U. Use of baseline 18F-FDG PET/CT to identify initial sub-volumes associated with local failure after concomitant chemoradiotherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2019;Volume 105(Issue 1, Supplement): Page E329 Zwanenburg, 2018, Why validation of prognostic models matters?, Radiot Oncol: J Eur Soc Ther Radiol Oncol., 127, 370, 10.1016/j.radonc.2018.03.004 Tixier, 2016, Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer, J Nucl Med., 57, 1033, 10.2967/jnumed.115.166918 Lim, 2011, Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer, Int J Radiat Oncol Biol Phys., 79, 348, 10.1016/j.ijrobp.2009.10.075 Fedorov, 2012, 3D Slicer as an image computing platform for the Quantitative Imaging Network, Magn Reson Imaging, 30, 1323, 10.1016/j.mri.2012.05.001 Mattes, 2003, PET-CT image registration in the chest using free-form deformations, IEEE Trans Med Imaging, 22, 120, 10.1109/TMI.2003.809072 Hatt, 2009, A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET, IEEE Trans Med Imaging., 28, 881, 10.1109/TMI.2008.2012036 Hatt, 2011, PET functional volume delineation: a robustness and repeatability study, Eur J Nucl Med Mol Imaging., 38, 663, 10.1007/s00259-010-1688-6 Hatt, 2017, Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211, Med Phys, 44, e1, 10.1002/mp.12124 M. Hatt M-CD, F. Tixier, B. Badic, B. Laurent, D. Visvikis, C. Cheze Le Rest. Revisiting the identification of tumor sub-volumes predictive of residual uptake after (chemo)radiotherapy: influence of segmentation methods on 18F-FDG PET/CT images. Sci Rep, 2019.in press. Hatt, 2010, Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications, Int J Radiat Oncol Biol Phys, 77, 301, 10.1016/j.ijrobp.2009.08.018 Verma, 2018, Use of PET and other functional imaging to guide target delineation in radiation oncology, Semin Radiat Oncol, 28, 171, 10.1016/j.semradonc.2018.02.001 Prieto-Vila, 2017, Drug resistance driven by cancer stem cells and their niche, Int J Mol Sci, 18, 10.3390/ijms18122574 Tanderup, 2013, Dose-response for local control in image guided cervix brachytherapy in the retroEMBRACE study, ESTRO 2013 Dimopoulos, 2009, Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy, Radiot Oncol: J Eur Soc Ther Radiol Oncol., 93, 311, 10.1016/j.radonc.2009.07.001 Tan, 2019, Change in patterns of failure after image-guided brachytherapy for cervical cancer: analysis from the RetroEMBRACE study, Int J Radiat Oncol Biol Phys, 104, 895, 10.1016/j.ijrobp.2019.03.038 Chargari, 2016, Image-guided adaptive brachytherapy in cervical cancer: patterns of relapse by brachytherapy planning parameters, Brachytherapy, 15, 456, 10.1016/j.brachy.2016.04.006 Han, 2018, Prognostic Value of Volume-Based Metabolic Parameters of (18)F-FDG PET/CT in Uterine Cervical Cancer: A Systematic Review and Meta-Analysis, AJR Am J Roentgenol, 211, 1112, 10.2214/AJR.18.19734 Lucia, 2018, Prediction of outcome using pretreatment (18)F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy, Eur J Nucl Med Mol Imaging, 45, 768, 10.1007/s00259-017-3898-7 Chopra, 2020, MRI- and PET-guided interstitial brachytherapy for postsurgical vaginal recurrences of cervical cancer: results of phase II study, Int J Radiat Oncol Biol Phys, 106, 310, 10.1016/j.ijrobp.2019.10.037 Lai, 2017, Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer, BMC Cancer, 17, 825, 10.1186/s12885-017-3800-9 van de Bunt, 2006, Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression, Int J Radiat Oncol Biol Phys, 64, 189, 10.1016/j.ijrobp.2005.04.025 Jonsson, 2019, The rationale for MR-only treatment planning for external radiotherapy, Clin Transl Radiat Oncol, 18, 60, 10.1016/j.ctro.2019.03.005 Crehange, 2020, Interest of positron-emission tomography and magnetic resonance imaging for radiotherapy planning and control, Cancer Radiotherapie: journal de la Societe francaise de radiotherapie oncologique., 10.1016/j.canrad.2020.02.010 Kirisits, 2006, The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results, Int J Radiat Oncol Biol Phys., 65, 624, 10.1016/j.ijrobp.2006.01.036 Wang, 2019, Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy, British J Radiol, 92, 20190089, 10.1259/bjr.20190089 Chapman, 2018, Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy, J Contemp Brachytherapy, 10, 193, 10.5114/jcb.2018.76881 Zamboglou, 2018, Focal dose escalation for prostate cancer using (68)Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference, Radiat Oncol, 13, 81, 10.1186/s13014-018-1036-8 Zamboglou, 2018, The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer, Radiat Oncol, 13, 65, 10.1186/s13014-018-1014-1